CSL Ltd (CSLLY)
94.01
-1.28
(-1.34%)
USD |
OTCM |
May 17, 16:00
CSL Enterprise Value: 103.94B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 103.94B |
May 16, 2024 | 105.17B |
May 15, 2024 | 104.86B |
May 14, 2024 | 102.84B |
May 13, 2024 | 102.13B |
May 10, 2024 | 102.38B |
May 09, 2024 | 101.74B |
May 08, 2024 | 101.82B |
May 07, 2024 | 102.34B |
May 06, 2024 | 101.73B |
May 03, 2024 | 101.21B |
May 02, 2024 | 101.08B |
May 01, 2024 | 99.23B |
April 30, 2024 | 99.67B |
April 29, 2024 | 100.71B |
April 26, 2024 | 99.67B |
April 25, 2024 | 100.22B |
April 24, 2024 | 100.16B |
April 23, 2024 | 100.75B |
April 22, 2024 | 99.26B |
April 19, 2024 | 96.99B |
April 18, 2024 | 97.08B |
April 17, 2024 | 98.09B |
April 16, 2024 | 97.96B |
April 15, 2024 | 99.58B |
Date | Value |
---|---|
April 12, 2024 | 101.52B |
April 11, 2024 | 101.50B |
April 10, 2024 | 101.99B |
April 09, 2024 | 102.87B |
April 08, 2024 | 103.04B |
April 05, 2024 | 102.28B |
April 04, 2024 | 102.54B |
April 03, 2024 | 102.69B |
April 02, 2024 | 103.09B |
April 01, 2024 | 103.44B |
March 28, 2024 | 104.21B |
March 27, 2024 | 103.81B |
March 26, 2024 | 102.29B |
March 25, 2024 | 102.35B |
March 22, 2024 | 101.49B |
March 21, 2024 | 100.72B |
March 20, 2024 | 101.98B |
March 19, 2024 | 101.08B |
March 18, 2024 | 101.44B |
March 15, 2024 | 101.56B |
March 14, 2024 | 102.27B |
March 13, 2024 | 102.97B |
March 12, 2024 | 102.99B |
March 11, 2024 | 102.63B |
March 08, 2024 | 104.13B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
67.51B
Minimum
May 29 2019
118.27B
Maximum
Feb 03 2023
96.07B
Average
96.93B
Median
Nov 02 2020
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 5.257M |
Immutep Ltd | -- |
Opthea Ltd | 125.45M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | 2.71% |
Operating Earnings Yield | 2.77% |
Normalized Earnings Yield | 2.707 |